Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C7H5NO5 |
| Molecular Weight | 183.1183 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OC(=O)C1=C(O)C=CC(=C1)[N+]([O-])=O
InChI
InChIKey=PPDRLQLKHRZIJC-UHFFFAOYSA-N
InChI=1S/C7H5NO5/c9-6-2-1-4(8(12)13)3-5(6)7(10)11/h1-3,9H,(H,10,11)
| Molecular Formula | C7H5NO5 |
| Molecular Weight | 183.1183 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| 4-Carbamoylpiperidinium 5-nitro-salicylate. | 2010-12-15 |
|
| 4-(4-Nitro-benz-yl)pyridinium 5-nitro-salicylate. | 2010-04-24 |
|
| Bis[2-(ethoxy-carbonyl-amino)ethan-aminium] hexa-bromidostannate. | 2009-11-11 |
|
| Bis(μ-5-nitro-2-oxidobenzoato)bis-[triaqua-zinc(II)]. | 2009-11-04 |
|
| 2-All-yloxy-5-nitro-benzoic acid. | 2009-06-27 |
|
| Kinetic and safety assessment for salicylic acid nitration by nitric acid/acetic acid system. | 2006-06-30 |
|
| Guest-controlling effects on ER behaviors of beta-cyclodextrin polymer. | 2005-09-01 |
|
| The proton-transfer compounds of strychnine with achiral salicylic acids: strychninium 3,5-dinitrosalicylate and the strychninium 5-nitrosalicylate bis(5-nitrosalicylic acid) adduct. | 2005-07 |
|
| Equilibrium studies on chromium(III) complexes of salicylic acid and salicylic acid derivatives in aqueous solution. | 2004-11 |
Patents
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 21:08:54 GMT 2025
by
admin
on
Mon Mar 31 21:08:54 GMT 2025
|
| Record UNII |
82L9G7FYZ3
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
m7988
Created by
admin on Mon Mar 31 21:08:54 GMT 2025 , Edited by admin on Mon Mar 31 21:08:54 GMT 2025
|
PRIMARY | Merck Index | ||
|
96-97-9
Created by
admin on Mon Mar 31 21:08:54 GMT 2025 , Edited by admin on Mon Mar 31 21:08:54 GMT 2025
|
PRIMARY | |||
|
82L9G7FYZ3
Created by
admin on Mon Mar 31 21:08:55 GMT 2025 , Edited by admin on Mon Mar 31 21:08:55 GMT 2025
|
PRIMARY | |||
|
183
Created by
admin on Mon Mar 31 21:08:55 GMT 2025 , Edited by admin on Mon Mar 31 21:08:55 GMT 2025
|
PRIMARY | |||
|
7318
Created by
admin on Mon Mar 31 21:08:54 GMT 2025 , Edited by admin on Mon Mar 31 21:08:54 GMT 2025
|
PRIMARY | |||
|
202-548-8
Created by
admin on Mon Mar 31 21:08:54 GMT 2025 , Edited by admin on Mon Mar 31 21:08:54 GMT 2025
|
PRIMARY | |||
|
61281
Created by
admin on Mon Mar 31 21:08:55 GMT 2025 , Edited by admin on Mon Mar 31 21:08:55 GMT 2025
|
PRIMARY | |||
|
DTXSID2059142
Created by
admin on Mon Mar 31 21:08:55 GMT 2025 , Edited by admin on Mon Mar 31 21:08:55 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
